Health
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients – Healio
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant…
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant and hematopoietic-cell transplant recipients, according to a study published in Open Forum Infectious Diseases.
“Solid-organ and…
Continue Reading
-
General23 hours agoNothing to see here *wink wink*
-
General22 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
Noosa News8 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General11 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia